-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, KH16JDQDzhZnTrQ+Sp2lVbcrj9dU8sCjfgF2eZ/XZLdTmdvXoru1Un3nO2M7Us4i xezk154jJarrEV0Y4b2XFQ== 0001237899-03-000032.txt : 20031217 0001237899-03-000032.hdr.sgml : 20031217 20031217130934 ACCESSION NUMBER: 0001237899-03-000032 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20031215 FILED AS OF DATE: 20031217 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ROBERTS WILLIAM CENTRAL INDEX KEY: 0001226687 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19034 FILM NUMBER: 031059501 BUSINESS ADDRESS: STREET 1: REGENERON PHARMACEUTICALS INC STREET 2: 777 OLD SAW MILL RIVER CITY: TARRYTOWN STATE: NY ZIP: 10591 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000872589 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133444607 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 777 OLD SAW MILL RIVER RD CITY: TARRYTOWN STATE: NY ZIP: 10591-6707 BUSINESS PHONE: 9143477000 4 1 edgardoc.xml PRIMARY DOCUMENT X0201 4 2003-12-15 0 0000872589 REGENERON PHARMACEUTICALS INC REGN 0001226687 ROBERTS WILLIAM 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591 0 1 0 0 VP, Regulatory Development Common Stock 2003-12-15 4 A 0 3893 0 A 11024 D Incentive Stock Option (right to buy) 13 2003-12-15 4 A 0 5000 0 A 2013-12-15 Common Stock 5000 5000 D Non-Qualified Stock Option (right to buy) 13 2003-12-15 4 A 0 15000 0 A 2013-12-15 Common Stock 15000 15000 D Award of Restricted Stock under 2000 Long-Term Incentive Plan. The stock option award (combined incentive stock option and non-qualified stock option) vests in four equal annual installments, commencing one year after the date of grant. **/s/William G. Roberts 2003-12-17 -----END PRIVACY-ENHANCED MESSAGE-----